Financials

  • Market Capitalization 2.34 B
  • Employee 305
  • Founded 2018
  • CEO David Hung
  • Website www.nuvationbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VHJ0CC1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.91
Relación precio/flujo de caja
0.01

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1887
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.60 USD-1.13%-9.24%-9.44%+132.17%2.37 B USD
1896
KOD
Kodiak Sciences Inc - Common Stock
37.35 USD-0.98%-1.68%-10.17%+322.03%2.35 B USD
1906
BHVN
Biohaven Ltd. Common Shares
15.26 USD-0.91%+9.63%+12.29%-9.93%2.30 B USD
1907
OCUL
Ocular Therapeutix, Inc. - Common Stock
10.49 USD+1.25%-4.46%+25.63%-8.78%2.30 B USD

Noticias